The IDPC toolkit aims to build the capacity of civil society organisations for engaging with, and influencing, drug policy making processes at national, regional and international level.
Global Commission on Drug Policy calls for decriminalization of drug use and expansion of proven, science-based solutions to reduce Hepatitis C – Including sterile syringe access, safer injection facilities and prescription heroin programs.
This report provides a summary of what was discussed – and to highlight what was not – at this year’s meeting, and offers some analysis of the key discussions, debates and emerging new trends.
The trends and developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses.
This research concludes that the monetary benefits of California government exceeded the additional costs of California Substance Abuse and Crime Prevention Act implementation and provision of treatment.
The aim of this paper is to discuss the implementation of the new laws and to explore the key challenges in creating regulatory regimes for recreational marijuana.
This report documents the failure of current federal drug policies to support safety and highlights Canada’s escalating military role in the war of drugs.
Expenditure on health for Aboriginal and Torres Strait Islander people in 2010-11 was 1.47 times greater than the per non-Indigenous Australian in the same year.
This report reveals increasing health risks for people who inject drugs and significant community concern over the impact of injecting in public areas.
